EXICURE, INC. Letters of Credit Outstanding, Amount
EXICURE, INC. (XCUR) had Letters of Credit Outstanding, Amount of $1.20 million as of 2020-02-28, per its 10-Q filed 2020-08-12.
Discontinued › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2020-08-12
- 2020-02-28: Letters of Credit Outstanding, Amount $1.20M.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2020-02-28 | $1.20M 10-Q · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |